| 期刊論文| 1. | Clark, D. O.、Von Korff, M.、Saunders, K.、Baluch, W. M.、Simon, G. E.(1995)。A chronic disease score with empirically derived weights。Medical Care，33(8)，783-795。   | | 2. | Ash, A. S.、Zhao, Y.、Ellis, R. P.、Kramer, M. S.(2001)。Finging future high-cost cases: comparing prior cost versus diagnosis-based methods。Health Serv Res，36(6Pt2)，194-206。 | | 3. | Zhao, Y.、Ash, A. S.、Haughton, J.、McMillan, B.(2003)。Identifying future high cost cases: through predictive modeling。Dis Manage Health Outcomes，11，389-397。 | | 4. | Weiner, J. P.、Tucker, A. M.、Collins, A. M.(1998)。The development of risk-adjusted capitation payment system: The Maryland Medicaid Model。Journal of Ambulatory Care Management，21(suppl. 4)，29-52。 | | 5. | Reid, R. J.、Mac, William, L.、Verhulst, L.(2001)。Performance of the ACG case-mix system in two Canadian province。Med Care，39，86-99。 | | 6. | Reid, R. J.、Roos, N. P.、Mac William, L.、Frohlich, N.、Black, C.(2002)。Assessing population health care need using a claims-based ACG morbidity measure: a validation analysis in the Province of Manitoba。Health Serv Res，37，1345-1364。 | | 7. | Gilmer, T.、Kronick, R.、Fishman, P.、Ganiants, T. G.(2001)。The Medicaid Rx Model: pharmacy-based risk adjustment for public programs。Med Care，39(suppl ll)，1188-1202。 | | 8. | Sloan, K. L.、Sales, A. E.、Liu, C. F.(2003)。Construction and characteristics of the RxRisk-V: A VA-adapted pharmacy-based case-mix instrument。Med Care，41(suppl 6)，761-774。 | | 9. | Chang, R. E.、Lin, W. D.、Hsieh, C. J.、Chiang, T. L.(2002)。Healthcare utilization patterns and risk adjustment under Taiwan's national health insurance system。J Formos Med Assoc，101，52-59。 | | 10. | Johnson, R. E.、Hombrook, M. C.、Nichols, G. A.(1994)。Replicating the chronic disease score from automated pharmacy data。J Clin Epidemiol，47，1191-1199。 | | 11. | Lamers, L. M.(1999)。Pharmacy cost group: A risk-adjuster for capitation payments based on the use of prescribed drugs。Med Care，37(suppl 8)，824-830。 | | 12. | Lamers, L. M.(2001)。Health-based risk adjustment: Is inpatient and outpatient diagnostic information sufficient?。Inquiry，38，423-431。 | | 13. | van de Ven, W. P. M. M.、Lamers, L. M.、Rene, C. J. A.(2004)。Health-adjusted premium subsidies in the Netherlands。Health Aff，23，45-55。 | | 14. | Lamers, L. M.、van Vliet, R. C. J. A.(2004)。The Pharmacy-based cost group model: validating and adjusting the classification of medications for chronic condition to the Dutch situation。Health Policy，68，113-121。 | | 15. | Lin, W. D.、Chang, R. E.、Hsieh, C. J.、Yaung, C. L.、Chiang, T. L.(2003)。The development of a risk-adjusted capitation model based on principal inpatient diagnoses in Taiwan。J Formos Med Assoc，102，637-643。 | | 16. | Pope, G. C.、Adamache, K. W.、Ash, A. S.(1998)。Evaluatingalternative risk adjuster for Medicare。Health Care Financ Rev，20，109-129。 | | 17. | Ellis, R. P.、Pope, G. C.、Lezzoni, L.(1996)。Diagnosis-based risk adjustment for Medicare capitation payments。Health Care Financ Rev，17，101-127。 | | 18. | Chang, R. E.、Lai, C. L.(2005)。Use of diagnosis-based risk adjustment models to predict individual healthcare expenditure under the national health insurancesystem in Taiwan。J Formos Med Assoc，104，883-890。 | | 19. | Lamers, L. M.(2003)。Health-based risk adjustment: Improving the pharmacy-based cost group model to reduce gaming possibilities。Eur J Health Econ，4，107-114。 | | 20. | 張睿詒、賴秋伶(20040400)。風險校正因子：論人計酬醫療費用預測之基礎。臺灣公共衛生雜誌，23(2)，91-99。 延伸查詢 | 研究報告| 1. | 高雅慧。以ATC分類探討全民健保藥品之利用與分配。 延伸查詢 | 其他| 1. | WHO Collaborating Centre for Drug Statistics Methodology。Anatomical therapeutic Chemical (ATC) Classification Index，http://www.whocc.no/atcddd/， 2005/01/31。 | 圖書論文| 1. | van de Ven, W. P. M. M.、Ellis, R. P.(2000)。Risk adjustment in competitive health plan markets。Handbook of Health Economics。Amsterdam：Elsevier。 | |